1. Acta Neuropathol. 2020 Jun;139(6):1001-1024. doi: 10.1007/s00401-020-02145-7. 
Epub 2020 Mar 14.

Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal 
glucosylceramide export.

Martin S(#)(1), Smolders S(#)(2)(3)(4), Van den Haute C(5)(6), Heeman 
B(2)(3)(4), van Veen S(1), Crosiers D(2)(3)(7), Beletchi I(1), Verstraeten 
A(2)(3)(4), Gossye H(2)(3)(4)(7)(8), Gelders G(5), Pals P(3)(7), Hamouda NN(1), 
Engelborghs S(3)(8), Martin JJ(3), Eggermont J(1), De Deyn PP(3)(8), Cras 
P(3)(7), Baekelandt V(5)(6), Vangheluwe P(#)(9), Van Broeckhoven 
C(#)(10)(11)(12); BELNEU consortium.

Collaborators: van der Linden C, Maréchal E, Santens P, Vandenberghe W, Bergmans 
B.

Author information:
(1)Laboratory of Cellular Transport Systems, Department of Cellular and 
Molecular Medicine, KU Leuven Campus Gasthuisberg, O&N I Herestraat 49-bus 802, 
3000, Leuven, Belgium.
(2)Center for Molecular Neurology, VIB, University of Antwerp, 
Universiteitsplein 1, 2610, Antwerpen, Belgium.
(3)Institute Born-Bunge, Antwerp, Belgium.
(4)University of Antwerp, Antwerp, Belgium.
(5)Laboratory for Neurobiology and Gene Therapy, KU Leuven, Leuven, Belgium.
(6)Leuven Viral Vector Core, KU Leuven, Leuven, Belgium.
(7)Department of Neurology, Antwerp University Hospital, Edegem, Belgium.
(8)Department of Neurology and Memory Clinic, Antwerp Hospital Network, General 
Hospitals Middelheim and Hoge Beuken, Antwerp, Belgium.
(9)Laboratory of Cellular Transport Systems, Department of Cellular and 
Molecular Medicine, KU Leuven Campus Gasthuisberg, O&N I Herestraat 49-bus 802, 
3000, Leuven, Belgium. peter.vangheluwe@kuleuven.be.
(10)Center for Molecular Neurology, VIB, University of Antwerp, 
Universiteitsplein 1, 2610, Antwerpen, Belgium. 
christine.vanbroeckhoven@uantwerpen.vib.be.
(11)Institute Born-Bunge, Antwerp, Belgium. 
christine.vanbroeckhoven@uantwerpen.vib.be.
(12)University of Antwerp, Antwerp, Belgium. 
christine.vanbroeckhoven@uantwerpen.vib.be.
(#)Contributed equally

Comment in
    Acta Neuropathol. 2020 Sep;140(3):403-404. doi: 10.1007/s00401-020-02173-3.
    Acta Neuropathol. 2020 Sep;140(3):401-402. doi: 10.1007/s00401-020-02172-4.
    Acta Neuropathol. 2020 Nov;140(5):787-789. doi: 10.1007/s00401-020-02220-z.
    Acta Neuropathol. 2020 Nov;140(5):783-785. doi: 10.1007/s00401-020-02219-6.
    Acta Neuropathol. 2021 May;141(5):807-808. doi: 10.1007/s00401-021-02281-8.
    Acta Neuropathol. 2021 May;141(5):805-806. doi: 10.1007/s00401-021-02280-9.

Parkinson's disease (PD) is a progressive neurodegenerative brain disease 
presenting with a variety of motor and non-motor symptoms, loss of midbrain 
dopaminergic neurons in the substantia nigra pars compacta and the occurrence of 
α-synuclein-positive Lewy bodies in surviving neurons. Here, we performed whole 
exome sequencing in 52 early-onset PD patients and identified 3 carriers of 
compound heterozygous mutations in the ATP10B P4-type ATPase gene. Genetic 
screening of a Belgian PD and dementia with Lewy bodies (DLB) cohort identified 
4 additional compound heterozygous mutation carriers (6/617 PD patients, 0.97%; 
1/226 DLB patients, 0.44%). We established that ATP10B encodes a late 
endo-lysosomal lipid flippase that translocates the lipids glucosylceramide 
(GluCer) and phosphatidylcholine (PC) towards the cytosolic membrane leaflet. 
The PD associated ATP10B mutants are catalytically inactive and fail to provide 
cellular protection against the environmental PD risk factors rotenone and 
manganese. In isolated cortical neurons, loss of ATP10B leads to general 
lysosomal dysfunction and cell death. Impaired lysosomal functionality and 
integrity is well known to be implicated in PD pathology and linked to multiple 
causal PD genes and genetic risk factors. Our results indicate that recessive 
loss of function mutations in ATP10B increase risk for PD by disturbed lysosomal 
export of GluCer and PC. Both ATP10B and glucocerebrosidase 1, encoded by the PD 
risk gene GBA1, reduce lysosomal GluCer levels, emerging lysosomal GluCer 
accumulation as a potential PD driver.

DOI: 10.1007/s00401-020-02145-7
PMCID: PMC7244618
PMID: 32172343 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflicts of interest.